6th International Fresenius Conference: Endocrine Disruptors
Anja Staudenmaier
Konferenz Managerin und Akademieleitung
Telefon +49 231 75896-54
fresenius@akademie-fresenius.de
Annika Koterba
Veranstaltungsorganisation
Telefon +49 231 75896-74
Telefax +49 231 75896-53
akoterba@akademie-fresenius.de
Veranstaltungsort
Park Inn by Radisson Köln City West
Innere Kanalstraße 15
50823 Köln
Germany
Telefon +49 221 5701-0
Telefax +49 221 5701-999
koeln@proventhotels.com
www.pikcw.de
Themen:
Impact assessment – cost and benefits
- Burden of disease and costs of endocrine disrupting chemicals in the European Union
- Update from the European Commission on the ongoing impact assessment
- Industry view on latest developments in the endocrine disruptors impact assessment
Evidence
- Translating science to improve public health – new tools in epidemiology
- Concerns over low dose/thresholds/NMDRC in endocrine disruption
- Weight of evidence approach with some endocrine disruptor compounds
Regulatory update
- References to EDs in EU Law
- ECHA Report on the restriction process under Reach for endocrine active substances
- Identification of EDs as SVHC
Assessment
- The OECD conceptual framework for testing for endocrine effects
- EDSP List 1 Chemicals: assays results and WOE determinations
Adverse Outcome Pathways
- Adverse outcome pathways: a conceptual framework
- Endocrine disruptor related AOP development: OECD and ECETOC activities